Find profiles by research application.

AOD-9604

Modified C-terminal fragment of human growth hormone (hGH 177–191)

Dermorphin

Heptapeptide μ-opioid receptor agonist isolated from Phyllomedusa frog skin · Controlled substance / WADA prohibited

GHRP-2

Synthetic hexapeptide growth hormone secretagogue (GHRP); a.k.a. pralmorelin

Sermorelin

Synthetic GHRH(1–29) analogue · Historically FDA-approved (Geref; discontinued 2008)

GHRP-2

Synthetic hexapeptide growth hormone secretagogue (GHRP); a.k.a. pralmorelin

GHRP-6

First-generation synthetic hexapeptide growth hormone secretagogue (GHRP)

Hexarelin

Synthetic hexapeptide growth hormone secretagogue (GHRP)

Melanotan-1

Synthetic α-MSH analogue · FDA-approved (Scenesse / afamelanotide) for erythropoietic protoporphyria

Melanotan-2

Synthetic cyclic α-MSH analogue · Not approved for human use in any jurisdiction

PT-141

Melanocortin receptor agonist · FDA-approved (Vyleesi, as bremelanotide)

Mazdutide

Dual GLP-1 / glucagon receptor agonist · Conditionally approved in China; investigational elsewhere

Survodutide

Dual GLP-1 / glucagon receptor agonist · Investigational (Phase III ongoing)

Mazdutide

Dual GLP-1 / glucagon receptor agonist · Conditionally approved in China; investigational elsewhere

Survodutide

Dual GLP-1 / glucagon receptor agonist · Investigational (Phase III ongoing)

Semaglutide

GLP-1 receptor agonist · FDA-approved (Ozempic / Wegovy / Rybelsus)

Tirzepatide

Dual GIP / GLP-1 receptor agonist · FDA-approved (Mounjaro / Zepbound)

Selank

Synthetic tuftsin-derived heptapeptide

Semax

Synthetic ACTH(4–7)-derived heptapeptide analogue

Mazdutide

Dual GLP-1 / glucagon receptor agonist · Conditionally approved in China; investigational elsewhere

Retatrutide

Triple GIP / GLP-1 / glucagon receptor agonist · Investigational (Phase III ongoing)

Semaglutide

GLP-1 receptor agonist · FDA-approved (Ozempic / Wegovy / Rybelsus)

Tirzepatide

Dual GIP / GLP-1 receptor agonist · FDA-approved (Mounjaro / Zepbound)

Thymosin Beta-4

Naturally occurring actin-binding peptide

Cerebrolysin

Neuropeptide / amino-acid mixture derived from porcine brain tissue · Approved in multiple jurisdictions (not US/UK); Cochrane evidence is mixed

SS-31

Mitochondria-targeted tetrapeptide (Szeto-Schiller-31 / elamipretide)

Hexarelin

Synthetic hexapeptide growth hormone secretagogue (GHRP)

MOTS-c

Mitochondrial-derived peptide (mitochondrial 12S rRNA open reading frame product)

Cagrilintide

Long-acting amylin analogue · Investigational

BPC-157

Synthetic gastric peptide fragment

AOD-9604

Modified C-terminal fragment of human growth hormone (hGH 177–191)

Melanotan-2

Synthetic cyclic α-MSH analogue · Not approved for human use in any jurisdiction

GHK-Cu

Copper-binding tripeptide complex

IGF-1 LR3

Recombinant long Arg3 analogue of insulin-like growth factor 1

LL-37

Human cathelicidin antimicrobial peptide (C-terminal cleavage of hCAP-18)

LL-37

Human cathelicidin antimicrobial peptide (C-terminal cleavage of hCAP-18)

AHK-Cu

Copper-binding tripeptide (Ala-His-Lys) studied alongside GHK-Cu in skin and hair research

AOD-9604

Modified C-terminal fragment of human growth hormone (hGH 177–191)

Kisspeptin-10

Endogenous KISS1-receptor agonist fragment

Thymosin Alpha-1

Synthetic 28-residue immunomodulatory peptide · Approved in multiple jurisdictions (not FDA-approved in the US)

VIP

Endogenous 28-residue neuropeptide (Vasoactive Intestinal Peptide)

Thymosin Beta-4

Naturally occurring actin-binding peptide

Tirzepatide

Dual GIP / GLP-1 receptor agonist · FDA-approved (Mounjaro / Zepbound)

GHRP-6

First-generation synthetic hexapeptide growth hormone secretagogue (GHRP)

Semaglutide

GLP-1 receptor agonist · FDA-approved (Ozempic / Wegovy / Rybelsus)

MGF

Mechano-growth factor — alternatively spliced IGF-1 isoform (IGF-1Ec) E-domain peptide

GHK-Cu

Copper-binding tripeptide complex

Thymosin Beta-4

Naturally occurring actin-binding peptide

GHK

Glycyl-L-histidyl-L-lysine — endogenous tripeptide (uncomplexed form of GHK-Cu)

PE 22-28

Shortened spadin analog · TREK-1 channel inhibitor · Preclinical only

FOX04-DRI

Synthetic D-retro-inverso senolytic peptide · Preclinical only

IGF-1 LR3

Recombinant long Arg3 analogue of insulin-like growth factor 1

Cartalax

Khavinson short peptide · Ala-Glu-Asp tripeptide · Preclinical only

BPC-157

Synthetic gastric peptide fragment

Melanotan-2

Synthetic cyclic α-MSH analogue · Not approved for human use in any jurisdiction

PT-141

Melanocortin receptor agonist · FDA-approved (Vyleesi, as bremelanotide)

Pinealon

Khavinson short peptide · Glu-Asp-Arg tripeptide · Preclinical only

Thymosin Alpha-1

Synthetic 28-residue immunomodulatory peptide · Approved in multiple jurisdictions (not FDA-approved in the US)

Cagrilintide

Long-acting amylin analogue · Investigational

Tesamorelin

Synthetic GHRH(1–44) analogue · FDA-approved (Egrifta)

Ipamorelin

Selective ghrelin / GHS-R1a receptor agonist (GHRP)

Cerebrolysin

Neuropeptide / amino-acid mixture derived from porcine brain tissue · Approved in multiple jurisdictions (not US/UK); Cochrane evidence is mixed

DSIP

Endogenous nonapeptide implicated in delta-sleep induction

Semax

Synthetic ACTH(4–7)-derived heptapeptide analogue

AHK-Cu

Copper-binding tripeptide (Ala-His-Lys) studied alongside GHK-Cu in skin and hair research

AHK-Cu

Copper-binding tripeptide (Ala-His-Lys) studied alongside GHK-Cu in skin and hair research

GHK

Glycyl-L-histidyl-L-lysine — endogenous tripeptide (uncomplexed form of GHK-Cu)

GHRP-6

First-generation synthetic hexapeptide growth hormone secretagogue (GHRP)

Melanotan-2

Synthetic cyclic α-MSH analogue · Not approved for human use in any jurisdiction

KPV

C-terminal tripeptide of α-melanocyte-stimulating hormone (α-MSH 11-13)

SNAP-8

Cosmetic-research peptide · Acetyl octapeptide-3 · SNARE-complex–targeting analog

Sermorelin

Synthetic GHRH(1–29) analogue · Historically FDA-approved (Geref; discontinued 2008)

Tesamorelin

Synthetic GHRH(1–44) analogue · FDA-approved (Egrifta)

CJC-1295

Synthetic GHRH analogue (with or without DAC)

VIP

Endogenous 28-residue neuropeptide (Vasoactive Intestinal Peptide)

GHK

Glycyl-L-histidyl-L-lysine — endogenous tripeptide (uncomplexed form of GHK-Cu)

Melanotan-1

Synthetic α-MSH analogue · FDA-approved (Scenesse / afamelanotide) for erythropoietic protoporphyria

GHK-Cu

Copper-binding tripeptide complex

PT-141

Melanocortin receptor agonist · FDA-approved (Vyleesi, as bremelanotide)

BPC-157

Synthetic gastric peptide fragment

Epitalon

Synthetic pineal tetrapeptide

GHRP-2

Synthetic hexapeptide growth hormone secretagogue (GHRP); a.k.a. pralmorelin

GHK

Glycyl-L-histidyl-L-lysine — endogenous tripeptide (uncomplexed form of GHK-Cu)

Ipamorelin

Selective ghrelin / GHS-R1a receptor agonist (GHRP)

CJC-1295

Synthetic GHRH analogue (with or without DAC)

Hexarelin

Synthetic hexapeptide growth hormone secretagogue (GHRP)

GHRP-6

First-generation synthetic hexapeptide growth hormone secretagogue (GHRP)

Semaglutide

GLP-1 receptor agonist · FDA-approved (Ozempic / Wegovy / Rybelsus)

Retatrutide

Triple GIP / GLP-1 / glucagon receptor agonist · Investigational (Phase III ongoing)

SS-31

Mitochondria-targeted tetrapeptide (Szeto-Schiller-31 / elamipretide)

Thymalin

Polypeptide complex extracted from thymus tissue · Russian Federation registered preparation

Tesamorelin

Synthetic GHRH(1–44) analogue · FDA-approved (Egrifta)

Tesamorelin

Synthetic GHRH(1–44) analogue · FDA-approved (Egrifta)

LL-37

Human cathelicidin antimicrobial peptide (C-terminal cleavage of hCAP-18)

IGF-1 LR3

Recombinant long Arg3 analogue of insulin-like growth factor 1

Thymosin Alpha-1

Synthetic 28-residue immunomodulatory peptide · Approved in multiple jurisdictions (not FDA-approved in the US)

Selank

Synthetic tuftsin-derived heptapeptide

Tirzepatide

Dual GIP / GLP-1 receptor agonist · FDA-approved (Mounjaro / Zepbound)

ARA-290

Non-hematopoietic erythropoietin-derived 11-residue peptide (cibinetide)

KPV

C-terminal tripeptide of α-melanocyte-stimulating hormone (α-MSH 11-13)

Thymosin Alpha-1

Synthetic 28-residue immunomodulatory peptide · Approved in multiple jurisdictions (not FDA-approved in the US)

ARA-290

Non-hematopoietic erythropoietin-derived 11-residue peptide (cibinetide)

Oxytocin

Endogenous nonapeptide hormone · FDA-approved (Pitocin) for labour induction and postpartum uterine atony

Cartalax

Khavinson short peptide · Ala-Glu-Asp tripeptide · Preclinical only

Kisspeptin-10

Endogenous KISS1-receptor agonist fragment

CJC-1295

Synthetic GHRH analogue (with or without DAC)

Sermorelin

Synthetic GHRH(1–29) analogue · Historically FDA-approved (Geref; discontinued 2008)

Survodutide

Dual GLP-1 / glucagon receptor agonist · Investigational (Phase III ongoing)

GHRP-2

Synthetic hexapeptide growth hormone secretagogue (GHRP); a.k.a. pralmorelin

KPV

C-terminal tripeptide of α-melanocyte-stimulating hormone (α-MSH 11-13)

Cartalax

Khavinson short peptide · Ala-Glu-Asp tripeptide · Preclinical only

MOTS-c

Mitochondrial-derived peptide (mitochondrial 12S rRNA open reading frame product)

PT-141

Melanocortin receptor agonist · FDA-approved (Vyleesi, as bremelanotide)

SNAP-8

Cosmetic-research peptide · Acetyl octapeptide-3 · SNARE-complex–targeting analog

SS-31

Mitochondria-targeted tetrapeptide (Szeto-Schiller-31 / elamipretide)

MOTS-c

Mitochondrial-derived peptide (mitochondrial 12S rRNA open reading frame product)

Retatrutide

Triple GIP / GLP-1 / glucagon receptor agonist · Investigational (Phase III ongoing)

MGF

Mechano-growth factor — alternatively spliced IGF-1 isoform (IGF-1Ec) E-domain peptide

Semax

Synthetic ACTH(4–7)-derived heptapeptide analogue

SS-31

Mitochondria-targeted tetrapeptide (Szeto-Schiller-31 / elamipretide)

Thymosin Beta-4

Naturally occurring actin-binding peptide

Cagrilintide

Long-acting amylin analogue · Investigational

Survodutide

Dual GLP-1 / glucagon receptor agonist · Investigational (Phase III ongoing)

Retatrutide

Triple GIP / GLP-1 / glucagon receptor agonist · Investigational (Phase III ongoing)

Mazdutide

Dual GLP-1 / glucagon receptor agonist · Conditionally approved in China; investigational elsewhere

Oxytocin

Endogenous nonapeptide hormone · FDA-approved (Pitocin) for labour induction and postpartum uterine atony

Dermorphin

Heptapeptide μ-opioid receptor agonist isolated from Phyllomedusa frog skin · Controlled substance / WADA prohibited

AHK-Cu

Copper-binding tripeptide (Ala-His-Lys) studied alongside GHK-Cu in skin and hair research

Oxytocin

Endogenous nonapeptide hormone · FDA-approved (Pitocin) for labour induction and postpartum uterine atony

Sermorelin

Synthetic GHRH(1–29) analogue · Historically FDA-approved (Geref; discontinued 2008)

KPV

C-terminal tripeptide of α-melanocyte-stimulating hormone (α-MSH 11-13)

Kisspeptin-10

Endogenous KISS1-receptor agonist fragment

CJC-1295

Synthetic GHRH analogue (with or without DAC)

Dermorphin

Heptapeptide μ-opioid receptor agonist isolated from Phyllomedusa frog skin · Controlled substance / WADA prohibited

MGF

Mechano-growth factor — alternatively spliced IGF-1 isoform (IGF-1Ec) E-domain peptide

Ipamorelin

Selective ghrelin / GHS-R1a receptor agonist (GHRP)

Melanotan-1

Synthetic α-MSH analogue · FDA-approved (Scenesse / afamelanotide) for erythropoietic protoporphyria

Pinealon

Khavinson short peptide · Glu-Asp-Arg tripeptide · Preclinical only

Thymalin

Polypeptide complex extracted from thymus tissue · Russian Federation registered preparation

VIP

Endogenous 28-residue neuropeptide (Vasoactive Intestinal Peptide)

IGF-1 LR3

Recombinant long Arg3 analogue of insulin-like growth factor 1

Kisspeptin-10

Endogenous KISS1-receptor agonist fragment

Selank

Synthetic tuftsin-derived heptapeptide

Ipamorelin

Selective ghrelin / GHS-R1a receptor agonist (GHRP)

Hexarelin

Synthetic hexapeptide growth hormone secretagogue (GHRP)

Semax

Synthetic ACTH(4–7)-derived heptapeptide analogue

PE 22-28

Shortened spadin analog · TREK-1 channel inhibitor · Preclinical only

AOD-9604

Modified C-terminal fragment of human growth hormone (hGH 177–191)

Pinealon

Khavinson short peptide · Glu-Asp-Arg tripeptide · Preclinical only

FOX04-DRI

Synthetic D-retro-inverso senolytic peptide · Preclinical only

Thymosin Alpha-1

Synthetic 28-residue immunomodulatory peptide · Approved in multiple jurisdictions (not FDA-approved in the US)

LL-37

Human cathelicidin antimicrobial peptide (C-terminal cleavage of hCAP-18)

Epitalon

Synthetic pineal tetrapeptide

MOTS-c

Mitochondrial-derived peptide (mitochondrial 12S rRNA open reading frame product)

DSIP

Endogenous nonapeptide implicated in delta-sleep induction

ARA-290

Non-hematopoietic erythropoietin-derived 11-residue peptide (cibinetide)

Oxytocin

Endogenous nonapeptide hormone · FDA-approved (Pitocin) for labour induction and postpartum uterine atony

DSIP

Endogenous nonapeptide implicated in delta-sleep induction

Epitalon

Synthetic pineal tetrapeptide

BPC-157

Synthetic gastric peptide fragment

Thymalin

Polypeptide complex extracted from thymus tissue · Russian Federation registered preparation

FOX04-DRI

Synthetic D-retro-inverso senolytic peptide · Preclinical only

SNAP-8

Cosmetic-research peptide · Acetyl octapeptide-3 · SNARE-complex–targeting analog

GHK-Cu

Copper-binding tripeptide complex

ARA-290

Non-hematopoietic erythropoietin-derived 11-residue peptide (cibinetide)

Cerebrolysin

Neuropeptide / amino-acid mixture derived from porcine brain tissue · Approved in multiple jurisdictions (not US/UK); Cochrane evidence is mixed

PE 22-28

Shortened spadin analog · TREK-1 channel inhibitor · Preclinical only

Cerebrolysin

Neuropeptide / amino-acid mixture derived from porcine brain tissue · Approved in multiple jurisdictions (not US/UK); Cochrane evidence is mixed

VIP

Endogenous 28-residue neuropeptide (Vasoactive Intestinal Peptide)

Melanotan-1

Synthetic α-MSH analogue · FDA-approved (Scenesse / afamelanotide) for erythropoietic protoporphyria

Selank

Synthetic tuftsin-derived heptapeptide

Dermorphin

Heptapeptide μ-opioid receptor agonist isolated from Phyllomedusa frog skin · Controlled substance / WADA prohibited